4-((9-(3-hydroxypropyl)-6-((4-(morpholinomethyl)phenyl)amino)-9H-purin-2-yl)amino)butan-1-ol

ID: ALA4525165

PubChem CID: 155512081

Max Phase: Preclinical

Molecular Formula: C23H33N7O3

Molecular Weight: 455.56

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  OCCCCNc1nc(Nc2ccc(CN3CCOCC3)cc2)c2ncn(CCCO)c2n1

Standard InChI:  InChI=1S/C23H33N7O3/c31-12-2-1-8-24-23-27-21(20-22(28-23)30(17-25-20)9-3-13-32)26-19-6-4-18(5-7-19)16-29-10-14-33-15-11-29/h4-7,17,31-32H,1-3,8-16H2,(H2,24,26,27,28)

Standard InChI Key:  JFBMYNINNITHEP-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   19.0899  -29.8828    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.0888  -30.7103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8036  -31.1231    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.8019  -29.4701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5172  -29.8792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5174  -30.7057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3036  -30.9608    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.7891  -30.2921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3032  -29.6237    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.3741  -31.1222    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.7993  -28.6452    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.5126  -28.2305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2261  -28.6432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9389  -28.2293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9368  -27.4035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2161  -26.9933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5063  -27.4096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2956  -31.7829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0060  -32.2024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7244  -31.7968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4348  -32.2162    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.6496  -26.9879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3658  -27.3974    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.3634  -28.2212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0756  -28.6306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7907  -28.2185    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.7891  -27.3926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0724  -26.9787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6599  -30.7092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9452  -31.1211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2310  -30.7079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5162  -31.1199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8021  -30.7068    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  2 10  1  0
  4 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
  7 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 15 22  1  0
 22 23  1  0
 23 24  1  0
 23 28  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 10 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4525165

    ---

Associated Targets(Human)

PDGFRA Tclin Platelet-derived growth factor receptor alpha (5682 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EOL1 (427 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCC827 (1172 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BJ (6930 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 455.56Molecular Weight (Monoisotopic): 455.2645AlogP: 1.97#Rotatable Bonds: 12
Polar Surface Area: 120.59Molecular Species: NEUTRALHBA: 10HBD: 4
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.98CX LogP: 1.09CX LogD: 0.95
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.30Np Likeness Score: -1.37

References

1. Řezníčková E, Gucký T, Kováčová V, Ajani H, Jorda R, Kryštof V..  (2019)  Activity of 2,6,9-trisubstituted purines as potent PDGFRα kinase inhibitors with antileukaemic activity.,  182  [PMID:31514019] [10.1016/j.ejmech.2019.111663]

Source